- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT05103462
Telehealth Physical Therapy for Chronic Back Pain - Ancillary Study to NCT03859713 (TeleOPT)
Observational Study of Telehealth Physical Therapy Provided for Persons With Chronic Low Back Pain
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
At the time of the onset of the COVID pandemic, the research team was conducting a clinical trial (the OPTIMIZE trial) investigating different nonpharmacologic treatments for persons with chronic low back pain (NCT03859713). One intervention arm in this trial is in-person physical therapy. COVID-related restrictions on in-person care prompted suspension of the OPTIMIZE trial. In order to accommodate persons in the midst of receiving treatment at the time of suspension, the study team adapted the in-person protocol for physical therapy for telehealth delivery using two-way, real-time video sessions. Because of the lack of research examining the feasibility of telehealth physical therapy provided in this manner, the study team decided to conduct a pilot study to examine the feasibility of the telehealth protocol.
This study was a prospective, longitudinal cohort of persons with chronic LBP seeking care in one of three healthcare systems; University of Utah Health and Intermountain Healthcare in Salt Lake City, Utah, and Johns Hopkins Medicine in Baltimore, Maryland. All participants were offered up to 8 weekly sessions of telehealth physical therapy. Outcomes included measures of acceptability, appropriateness, feasibility and fidelity as well as effectiveness measures including the Oswestry Disability Index and the PROMIS-29 health domains. Assessments occurred at baseline and after 10- and 26-weeks.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Maryland
-
Baltimore, Maryland, États-Unis, 21287
- Johns Hopkins University
-
-
Utah
-
Salt Lake City, Utah, États-Unis, 84107
- Intermountain Health Care
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age 18 - 64 years at the time of enrollment.
- Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.
- Healthcare visit for LBP in the past 90 days.
- At least moderate levels of pain and disability requiring ODI score >24 and pain intensity rating > 4.
Exclusion Criteria:
- Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
- Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.
- Knowingly pregnant
- Unable to participate in telehealth due to lack of technology or internet access
- Has received physical therapy for LBP in prior 90 days
- Currently receiving substance use disorder treatment
- Any lumbar spine surgery in the past year.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Telehealth Physical Therapy
Weekly sessions of education, advice and exercise instruction provided by a licensed physical therapist using real-time, interactive video conferencing platform.
|
Weekly sessions of physical therapy provided using two-way, interactive, video technology consisting of education, advice and exercise instruction.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Participant Satisfaction with Telehealth Treatment
Délai: 10-weeks
|
Survey of participants evaluating treatment satisfaction
|
10-weeks
|
|
Rate of refusal to participate
Délai: Baseline
|
Ratio of persons entering the study among all those eligibility for enrollment
|
Baseline
|
|
Rate of enrolled participants initiating telehealth treatment
Délai: 10-weeks
|
Ratio of persons attending at least 1 treatment session among all those enrolled
|
10-weeks
|
|
Number of sessions
Délai: 10-weeks
|
Number of telehealth physical therapy sessions attended
|
10-weeks
|
|
Change in Oswestry from baseline to 10-weeks
Délai: baseline, 10 weeks
|
10 item measure of back pain-related disability
|
baseline, 10 weeks
|
|
Change in Oswestry from baseline to 26-weeks
Délai: baseline, 26 weeks
|
10 item measure of back pain-related disability
|
baseline, 26 weeks
|
|
Change in Pain Interference from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Pain Interference from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Pain Intensity from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
|
baseline, 10 weeks
|
|
Change in Pain Intensity from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale
|
baseline, 26 weeks
|
|
Change in Fatigue from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Fatigue from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Sleep Disturbance from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Sleep Disturbance from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Anxiety from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Anxiety from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Depression from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Depression from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Social Role Participation from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Social Role Participation from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Physical Function from baseline to 10 weeks
Délai: baseline, 10 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 10 weeks
|
|
Change in Physical Function from baseline to 26 weeks
Délai: baseline, 26 weeks
|
PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10
|
baseline, 26 weeks
|
|
Change in Pain Self-Efficacy Scale from baseline to 10 weeks
Délai: baseline, 10 weeks
|
10-item measure of confidence in performing activities even with pain
|
baseline, 10 weeks
|
|
Change in Pain Self-Efficacy Scale from baseline to 26 weeks
Délai: baseline, 26 weeks
|
10-item measure of confidence in performing activities even with pain
|
baseline, 26 weeks
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Julie Fritz, PT, PhD, University of Utah
Publications et liens utiles
Publications générales
- Skolasky RL, Wegener ST, Aaron RV, Ephraim P, Brennan G, Greene T, Lane E, Minick K, Hanley AW, Garland EL, Fritz JM. The OPTIMIZE study: protocol of a pragmatic sequential multiple assessment randomized trial of nonpharmacologic treatment for chronic, nonspecific low back pain. BMC Musculoskelet Disord. 2020 May 11;21(1):293. doi: 10.1186/s12891-020-03324-z.
- Fritz JM, Minick KI, Brennan GP, McGee T, Lane E, Skolasky RL, Thackeray A, Bardsley T, Wegener ST, Hunter SJ. Outcomes of Telehealth Physical Therapy Provided Using Real-Time, Videoconferencing for Patients With Chronic Low Back Pain: A Longitudinal Observational Study. Arch Phys Med Rehabil. 2022 Oct;103(10):1924-1934. doi: 10.1016/j.apmr.2022.04.016. Epub 2022 Jun 3.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB_00116150
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .